Higher Vitamin D Levels before Methotrexate Therapy Initiation Are Associated with Lower Subsequent Mortality in Patients with Rheumatoid Arthritis
Nutrients · 2024
DOI: 10.3390/nu16030401 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrients, 2024. Verfasst von Shahdi K Malakooti und 13 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Vitamin D Deficiency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CSRD VA, United States Department of Veterans Affairs, VA Merit funding.
Abstract (Originalsprache)
(1) Vitamin D deficiency is associated with mortality in the general population and has been observed in one rheumatoid arthritis (RA) cohort. Here, we investigate the relationship between 25-hydroxyvitamin D (25(OH)D) levels before methotrexate (MTX) therapy initiation in patients with RA and the subsequent all-cause mortality in a national Veterans Affairs (VA) cohort. (2) This is a retrospective study on RA patients time-oriented around the initial MTX prescription and 25(OH)D levels before starting MTX. We examined survival in patients with 25(OH)D levels > 50 nmol/L and ≤50 nmol/L using the Cox Proportional Hazard Model and fully adjusted for risk factors. (3) In total, 15,109 RA patients were included in the nationwide cohort. RA patients with 25(OH)D levels > 50 nmol/L before starting MTX had a 28% reduced risk of mortality when compared to those with levels ≤ 50 nmol/L (HR: 0.72, CI: 0.64–0.80, p < 0.001) after adjusting for traditional risk factors. (4) In this national RA cohort receiving standard-of-care MTX, patients with 25(OH)D levels > 50 nmol/L have a lower subsequent mortality when compared to those with 25(OH)D levels ≤ 50 nmol/L. It remains to be determined whether increasing Vitamin D levels in RA patients initially found to be Vitamin D deficient impacts their all-cause mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
- Department of Medicine, MetroHealth Medical Center, Cleveland, OH 44109, USA.
- Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 44106, USA.
- University Hospitals Cleveland Medical Center, Cleveland, OH 44106, USA.
ORCID-Profile: Alyssa Lange, Carey L Shive, Donald D Anthony
Förderung
- CSRD VA
- United States Department of Veterans Affairs
- VA Merit funding
Zitieren
APA
Malakooti, S. K., Siddiqui, H., Wilson, B., Bej, T., O'Mara, M., Desotelle, A., Lange, A., Shive, C. L., Singer, N. G., McComsey, G. A., Kostadinova, L., Mattar, M., Zidar, D. A., & Anthony, D. D. (2024). Higher Vitamin D Levels before Methotrexate Therapy Initiation Are Associated with Lower Subsequent Mortality in Patients with Rheumatoid Arthritis. Nutrients. https://doi.org/10.3390/nu16030401
Vancouver
Malakooti SK, Siddiqui H, Wilson B, Bej T, O'Mara M, Desotelle A, et al. Higher Vitamin D Levels before Methotrexate Therapy Initiation Are Associated with Lower Subsequent Mortality in Patients with Rheumatoid Arthritis. Nutrients. 2024. doi:10.3390/nu16030401
BibTeX
@article{Malakooti2024,
author = {Malakooti, Shahdi K and Siddiqui, Hinnah and Wilson, Brigid and Bej, Taissa and O'Mara, Megan and Desotelle, Alexandra and Lange, Alyssa and Shive, Carey L and Singer, Nora G and McComsey, Grace A and Kostadinova, Lenche and Mattar, Maya and Zidar, David A and Anthony, Donald D},
title = {Higher Vitamin D Levels before Methotrexate Therapy Initiation Are Associated with Lower Subsequent Mortality in Patients with Rheumatoid Arthritis},
journal = {Nutrients},
year = {2024},
doi = {10.3390/nu16030401}
}
EUVIMED